Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 84,767 More Arrow 94,082 Less Arrow 75,114
Financial expenses 13 Less Arrow 3 More Arrow 302
Earnings before taxes 49,958 More Arrow 55,076 Less Arrow 19,151
Total assets 722,814 Less Arrow 719,770 Less Arrow 642,018
Current assets 240,862 Less Arrow 225,223 Less Arrow 184,855
Current liabilities 53,728 Less Arrow 19,767 Less Arrow 16,305
Equity capital 665,759 More Arrow 696,200 Less Arrow 621,776
- share capital 220,385 More Arrow 236,023 Less Arrow 228,929

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 92.1% More Arrow 96.7% More Arrow 96.8%
Turnover per employee
Profit as a percentage of turnover 58.9% Less Arrow 58.5% Less Arrow 25.5%
Return on assets (ROA) 6.9% More Arrow 7.7% Less Arrow 3.0%
Current ratio 448.3% More Arrow 1139.4% Less Arrow 1133.7%
Return on equity (ROE) 7.5% More Arrow 7.9% Less Arrow 3.1%
Change turnover -3,081 More Arrow 16,640 Less Arrow -8,477
Change turnover % -4% More Arrow 21% Less Arrow -10%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.